A multicenter, randomized phase III study of docetaxel + cisplatin (DC) and docetaxel + carboplatin (DCB) vs. vinorelbine + cisplatin (VC) in chemotherapy-naive patients with advanced and metastatic non-small cell lung cancer. - Rodriguez,J.; Pawel,J.; Pluzanska,A.; Gorbounova,V.; Fosella,F.; Kaukel,E.; Mattson,K.; Millward,M.; Kim,Y.S.; Gamza,F.; Berille,J.; Belani,C.P. (Proc Am Soc Clin Oncol, 2001)